통화 / BMRN
BMRN: BioMarin Pharmaceutical Inc
55.91
USD
1.41
(2.59%)
BMRN 환율이 오늘 2.59%로 변동했습니다. 당일 이 종목은 저가가 54.20이고 고가는 55.94이었습니다.
BioMarin Pharmaceutical Inc 변동을 참고하세요. 실시간 쿼트는 여러분이 시장 변동에 빠르게 대처하는데에 도움이 될 것입니다. 차트 주기를 전환하여 환율의 추세와 변동을 분, 시간, 일, 주 및 월별로 모니터링할 수 있습니다. 이 정보를 사용하여 시장 변화를 예측하고 정보에 입각한 거래 결정을 내리십시오.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
BMRN News
- Biomarin at Morgan Stanley Conference: Strategic Growth and Innovation
- Are Options Traders Betting on a Big Move in BioMarin Pharmaceutical Stock?
- PTC Therapeutics To Challenge BioMarin's Metabolic Disorder Treatment - BioMarin Pharmaceutical (NASDAQ:BMRN)
- This Duolingo Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Monday - Bullish (NYSE:BLSH), BioMarin Pharmaceutical (NASDAQ:BMRN)
- BioMarin’s PKU drug shows nearly 50% blood Phe reduction in teens
- BioMarin (BMRN) Down 4.6% Since Last Earnings Report: Can It Rebound?
- BioMarin Pharmaceutical Inc. (BMRN) Presents at Cantor Global Healthcare Conference 2025
- Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Value Stock
- Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Growth Stock
- BioMarin stock rating reiterated at Outperform by Oppenheimer on Voxzogo strength
- BioMarin stock price target raised to $95 by Bernstein following Inozyme acquisition
- BioMarin Pharmaceutical (BMRN) is a Top-Ranked Momentum Stock: Should You Buy?
- Why BioMarin Pharmaceutical (BMRN) is a Top Value Stock for the Long-Term
- Why BioMarin Pharmaceutical (BMRN) is a Top Growth Stock for the Long-Term
- BioMarin Discontinues Preclinical Drug Candidate, Advances BMN 333 Toward 2030 - BioMarin Pharmaceutical (NASDAQ:BMRN)
- BioMarin Beats on Q2 Earnings & Sales, Stock Gains on Raised '25 View
- 3 Best Stocks to Buy Now, 8/5/2025, According to Top Analysts - TipRanks.com
- BioMarin Pharmaceutical Inc. (BMRN) Q2 2025 Earnings Call Transcript
- BioMarin (BMRN) Q2 Revenue Jumps 16%
- BioMarin (BMRN) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
- BioMarin (BMRN) Q2 2025 Earnings Call Transcript
- Earnings call transcript: Biomarin beats Q2 2025 estimates, stock rises
- BioMarin Pharmaceutical (BMRN) Q2 Earnings and Revenues Surpass Estimates
- After-hours movers: Palantir, Hims & Hers, Vertex Pharma and more
일일 변동 비율
54.20
55.94
년간 변동
52.94
73.51
- 이전 종가
- 54.50
- 시가
- 54.46
- Bid
- 55.91
- Ask
- 56.21
- 저가
- 54.20
- 고가
- 55.94
- 볼륨
- 4.773 K
- 일일 변동
- 2.59%
- 월 변동
- -4.26%
- 6개월 변동
- -20.36%
- 년간 변동율
- -20.50%
11 9월, 목요일
08:00
ALL
- 활동
- 예측값
- 훑어보기
11:00
ALL
- 활동
- 예측값
- 훑어보기
12:30
USD
- 활동
- 예측값
- 0.2%
- 훑어보기
- 0.2%
12:30
USD
- 활동
- 예측값
- 0.3%
- 훑어보기
- 0.3%
12:30
USD
- 활동
- 예측값
- 2.9%
- 훑어보기
- 2.7%
12:30
USD
- 활동
- 예측값
- 3.3%
- 훑어보기
- 3.1%
12:30
USD
- 활동
- 예측값
- 훑어보기
- 0.2%
12:30
USD
- 활동
- 예측값
- 322.956
- 훑어보기
- 322.132
12:30
USD
- 활동
- 263 K
- 예측값
- 235 K
- 훑어보기
- 236 K
12:30
USD
- 활동
- 1.939 M
- 예측값
- 1.923 M
- 훑어보기
- 1.939 M
17:00
USD
- 활동
- 4.651%
- 예측값
- 훑어보기
- 4.813%
18:00
USD
- 활동
- $-344.8 B
- 예측값
- $-283.5 B
- 훑어보기
- $-291.1 B